fluoxetine has been researched along with nomifensine in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (35.90) | 18.7374 |
| 1990's | 6 (15.38) | 18.2507 |
| 2000's | 6 (15.38) | 29.6817 |
| 2010's | 13 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP | 1 |
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bush, LR; Campbell, UC; Engel, SR; Hardy, LW; Hewitt, MC; Koch, P; Ma, J; Malcolm, SC; Saraswat, LD; Schreiber, R; Shao, L; Spear, KL; Spicer, NA; Varney, MA; Wang, F | 1 |
| Campbell, JE; Campbell, UC; Engel, SR; Hardy, LW; Hewitt, MC; Ma, J; Malcolm, SC; Schreiber, R; Shao, L; Spear, KL; Spicer, NA; Varney, MA; Wang, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Campbell, UC; Engel, SR; Hardy, LW; Hewitt, MC; Jiang, ZD; Ma, J; Malcolm, SC; Schreiber, R; Shao, L; Spear, KL; Spicer, NA; Varney, MA; Wang, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Arunotayanun, W; Dalley, JW; Gibbons, S; Huang, XP; Iversen, L; Roth, BL; Setola, V; Treble, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Gale, K; Meloni, R | 1 |
| Köhler, R; Taneri, Z | 1 |
| Smith, DF | 1 |
| Ostrow, D | 1 |
| Lloyd, KG; Pilc, A; Thuret, F | 1 |
| Brown, TM; Evans, DL; Golden, RN; Miller, H | 1 |
| Jones, DJ; Stauderman, KA | 1 |
| Holman, RB; Snape, BM | 1 |
| Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
| Jackson, DM; Jenkins, OF | 2 |
| Jenner, P; Kelly, E; Marsden, CD | 1 |
| Bernasconi, S; Kostowski, W; Kozak, W; Valzelli, L | 1 |
| Shopsin, B | 1 |
| Jackson, BP; Wightman, RM | 1 |
| Bayer, BM; Berkeley, MB; Daussin, S; Hernandez, MC | 1 |
| Boja, JW; Brouard, A; Carroll, FI; Kuhar, MJ; Pelaprat, D; Rostene, W; Vial, M | 1 |
| De Oliveira, K; Hennings, EC; Kiss, JP; Toth, PT; Vizi, ES | 1 |
| Gembom, E; Lesch, KP; Mossner, R; Pan, Y; Peng, W; Simantov, R | 1 |
| Dziedzicka-Wasylewska, M; Filip, M; Inan, SY; Przegaliński, E; Wydra, K | 1 |
| Adkins, EM; Blakely, RD; Field, JR; Henry, LK; Newman, AH; Parnas, ML; Vaughan, RA; Zou, MF | 1 |
| Blaha, CD; Cooper, S; Harris, BT; Hitti, FL; Kim, U; Lee, KH; Leiter, JC; Roberts, DW | 1 |
| Diniz, PH; Gomez, MV; Gomez, RS; Guatimosim, C; Silva, JH | 1 |
| Arai, Y; Furuta, S; Hozumi, M; Ishigaki, S; Nakagawasai, O; Niijima, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K | 1 |
| Nikiforuk, A; Popik, P | 1 |
4 review(s) available for fluoxetine and nomifensine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone | 1988 |
Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Dextroamphetamine; Drug Interactions; Fluoxetine; Humans; Methyltyrosines; Mice; Motor Activity; Nialamide; Nomifensine; Nucleus Accumbens; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1985 |
2 trial(s) available for fluoxetine and nomifensine
| Article | Year |
|---|---|
Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nomifensine; Random Allocation | 1989 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
33 other study(ies) available for fluoxetine and nomifensine
| Article | Year |
|---|---|
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1987 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Mice; Naphthalenes; Neurotransmitter Uptake Inhibitors; Norepinephrine; Serotonin | 2011 |
Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.
Topics: Amines; Animals; Cyclization; Dopamine Uptake Inhibitors; Drug Design; Inhibitory Concentration 50; Mice; Molecular Structure; Norepinephrine; Serotonin; Stereoisomerism | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.
Topics: Animals; Antidepressive Agents; Dopamine Plasma Membrane Transport Proteins; Inhibitory Concentration 50; Isoindoles; Mice; Motor Activity; Norepinephrine Plasma Membrane Transport Proteins; Pyrroles; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Topics: Allyl Compounds; HEK293 Cells; Humans; Indoles; Magnetic Resonance Spectroscopy; Molecular Conformation; Propylamines; Protein Binding; Psychotropic Drugs; Receptors, Serotonin; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Tryptamines | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; Cocaine; Dopamine; Fetal Tissue Transplantation; Fluoxetine; Imipramine; Male; Neural Pathways; Neurotransmitter Uptake Inhibitors; Nomifensine; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Substantia Nigra | 1991 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock.
Topics: Animals; Antidepressive Agents; Cerebral Cortex; Desipramine; Dose-Response Relationship, Drug; Electroshock; Fluoxetine; gamma-Aminobutyric Acid; Hippocampus; Kinetics; Male; Monoamine Oxidase Inhibitors; Nomifensine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Serotonin Antagonists; Time Factors; Viloxazine | 1985 |
Characterization of sodium-dependent, high-affinity serotonin uptake in rat spinal cord synaptosomes.
Topics: Animals; Desipramine; Fluoxetine; Kinetics; Male; Nomifensine; Rats; Rats, Inbred Strains; Serotonin; Sodium; Spinal Cord; Synaptosomes; Temperature | 1985 |
The release of endogenous dopamine from rat striatum during incubation in vitro.
Topics: Animals; Brain Chemistry; Bridged Bicyclo Compounds; Corpus Striatum; Dopamine; Fluoxetine; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Nomifensine; Potassium; Rats; Rats, Inbred Strains; Time Factors | 1985 |
Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Clomipramine; Corpus Striatum; Desipramine; Dopamine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Nomifensine; Norepinephrine; Pyridines; Serotonin Antagonists | 1985 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Topics: Amphetamine; Animals; Catecholamines; Corpus Striatum; Desipramine; Dopamine; Female; Fluoxetine; Hydroxydopamines; Medial Forebrain Bundle; Nerve Endings; Nomifensine; Oxidopamine; Potassium Chloride; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra; Synaptosomes | 1985 |
Activity of desipramine, fluoxetine and nomifensine on spontaneous and p-CPA-induced muricidal aggression.
Topics: Aggression; Animals; Antidepressive Agents; Desipramine; Fenclonine; Fluoxetine; Humans; Male; Nomifensine; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Second generation antidepressants.
Topics: Antidepressive Agents, Tricyclic; Catecholamines; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Imipramine; Monoamine Oxidase Inhibitors; Nomifensine; Serotonin; Trazodone | 1980 |
Dynamics of 5-hydroxytryptamine released from dopamine neurons in the caudate putamen of the rat.
Topics: Animals; Carrier Proteins; Caudate Nucleus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Electrophysiology; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Nomifensine; Putamen; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses.
Topics: Animals; B-Lymphocytes; Cells, Cultured; Cocaine; Desipramine; Fluoxetine; Lidocaine; Lymphocyte Activation; Male; Mitogens; Monoamine Oxidase Inhibitors; Nomifensine; Rats; Rats, Sprague-Dawley; Spleen; T-Lymphocytes | 1994 |
Potent cocaine analogs inhibit [3H]dopamine uptake in rat mesencephalic cells in primary cultures: pharmacological selectivity of embryonic cocaine sites.
Topics: Animals; Binding Sites; Binding, Competitive; Biological Transport; Cell Membrane; Cells, Cultured; Cocaine; Desipramine; Dopamine; Embryo, Mammalian; Fluoxetine; Iodine Radioisotopes; Kinetics; Mesencephalon; Neurons; Nomifensine; Rats; Rats, Wistar; Stereoisomerism; Tritium | 1993 |
Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices.
Topics: Animals; Culture Techniques; Desipramine; Electric Stimulation; Electrophysiology; Fluoxetine; Hippocampus; Male; Neurons; Neurotransmitter Uptake Inhibitors; Nicotinic Antagonists; Nomifensine; Norepinephrine; Rats; Rats, Wistar; Receptors, Nicotinic; Sodium Channels; Superior Cervical Ganglion; Tetrodotoxin | 1999 |
Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carrier Proteins; Cells, Cultured; Dopamine Uptake Inhibitors; Fluoxetine; Imipramine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Nomifensine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium | 2001 |
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Antidepressive Agents; Biogenic Monoamines; Conditioning, Operant; Cyclohexanols; Cyclopropanes; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Milnacipran; Morphine; Morpholines; Naloxone; Narcotic Antagonists; Nomifensine; Rats; Rats, Wistar; Reboxetine; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Tramadol; Venlafaxine Hydrochloride | 2004 |
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amino Acid Sequence; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Blotting, Western; Cadmium; Cell Line; Cell Membrane; Citalopram; Clomipramine; Cocaine; Cysteine; Dopamine Uptake Inhibitors; Fluoxetine; HeLa Cells; Humans; Immunoprecipitation; Isoleucine; Kinetics; LLC-PK1 Cells; Mazindol; Methionine; Mice; Models, Chemical; Molecular Sequence Data; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Nomifensine; Protein Binding; Protein Structure, Tertiary; Protein Transport; Radiopharmaceuticals; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Stereoisomerism; Substrate Specificity; Tyrosine | 2006 |
Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: potential mechanism of action in Parkinson's disease.
Topics: Action Potentials; Animals; Behavior, Animal; Corpus Striatum; Desipramine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Female; Fluoxetine; Immunohistochemistry; In Vitro Techniques; Male; Nomifensine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Subthalamic Nucleus; Tyrosine 3-Monooxygenase | 2006 |
Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
Topics: Anesthetics, Inhalation; Animals; Cerebral Cortex; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Fluoxetine; Halothane; Male; Nomifensine; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Rats; Rats, Wistar; Tetrodotoxin; Transport Vesicles; Tritium | 2007 |
Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Ditiocarb; Dopamine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Injections, Intraventricular; Male; Mice; Microinjections; Motor Activity; Neural Pathways; Nomifensine; Nucleus Accumbens; p-Hydroxyamphetamine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Time Factors | 2010 |
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
Topics: Animals; Antidepressive Agents; Attention; Behavior, Animal; Citalopram; Cognition Disorders; Desipramine; Drug Administration Schedule; Fluoxetine; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Stress, Psychological; Time Factors | 2011 |